PhD Career Connections: 2011-2012 Seminar Series

connection-logo.jpgVanderbilt PhD Career Connections is a monthly seminar series about career options for PhD scientists. Speakers from a diverse range of exciting scientific careers present their career path and share insights from their professional experiences. The series is run by VUMC PhD students and postdoctoral fellows and sponsored by the BRET Office of Career Development. Advance registration is requested for all seminars. Click on the speaker name to register and view event details and speaker bios.

For more information on the series, to suggest a speaker, or to become a member of the PhD Career Connections Planning Committee, please contact Kate Stuart

 

2011-2012 PhD Career Connections

Month Topic Speaker
August (8/9/11) From Academics to Economic Development: A Journey Down the Non-Traditional Career Path, co-sponsored by the Biochemistry Student Association, Life Science Tennessee Graduate Alliance, and the Vanderbilt Postdoctoral Association Dr. Leslie Wisner-Lynch, President and CEO, Tennessee Technology Development Corporation, and Executive Director, BioTN Foundation
September (9/13/11) Biotechnology Panel Discussion with Dr. Eric Elmquist, Scientist, Biomimetic Therapeutics and Founder, Compliant Therapeutics; Dr. David Hout, Director of Research and Development, Insight Genetics
September (9/30/11) Science Policy Dr. Chiatogu Onyewu, AAAS Science and Technology Policy Fellow, Division of the Application of Research Discoveries, National Heart, Lung, and Blood Institute, NIH
December (12/14/11) Nonprofit Grants Management Dr. Jerome Jourquin, Scientific Grants Manager, Susan G. Komen for the Cure
January (1/16/12) Entrepreneurship, co-sponsored by the TechVenture Challenge Panel Discussion with Dr. Jim Stefansic, Co-Founder and COO, Pathfinder Therapeutics; and Dr. Mark Harris, CEO, Next GxDx
February (2/8/12) Clinical Research Management Dr. Ines Macias-Perez, Senior Program Manager, Hematologic Malignancies and Transplant Program, Sarah Cannon Research Institute
March (3/20/12) Regulatory Affairs, co-sponsored by the TechVenture Challenge Dr. Bryan Voss, Research Associate, Cumberland Pharmaceuticals
April (4/10/12) Business of Healthcare Panel Discussion with Mr. Chris Calton, Director of Banking, Avondale Partners (Healthcare Investment Banking); Mr. John Lam, Chief Creative Strategist and Co-Founder, Lam-Andrews (Healthcare Marketing/PR); Ms. Kim Ramko, Principal for Americas Life Sciences Sector Lead, Ernst & Young (Healthcare Consulting); and Ms. Rena Goins, Senior Director Specialty Markets, D2 Pharma Consulting (Healthcare Consulting).
May (5/29/12) Medical Science Liaison Dr. Kathy Amiri, Oncology Regional Medical Liaison, Amgen

 

 

 


 

lesliewisnerlynch.jpg

PhD Career Connections presents
Dr. Leslie Wisner-Lynch
President and CEO, Tennessee Technology Development Corporation
Executive Director, BioTN Foundation

From Academics to Economic Development: A Journey Down the Non-Traditional Career Path

Tuesday, August 9, 2011
4:00-5:00PM
512 Light Hall

Advance registration requested: https://www.surveymonkey.coms/PhDCareerConnections_Aug11

Co-sponsored by the BRET Office of Career Development, Life Science Tennessee Graduate Alliance, Biochemistry Student Association, and the Vanderbilt Postdoctoral Association

Dr. Leslie Wisner-Lynch is currently serving as President and CEO of the Tennessee Technology Development Corporation, a legislatively created, not-for-profit corporation that works in partnership with the state department of economic and community development to increase the formation, and expansion, of science and technology businesses in Tennessee. She is also a founding member, and part-time executive director of the BioTN Foundation, Inc, a not-for profit foundation committed to advancing life sciences knowledge and business development in the state of Tennessee through the collaborative of industry, K12 education and higher ed.

Dr. Wisner-Lynch also serves as the Governor’s designated Chair for the STEM Advisory Council for the STEM Innovation Network, the innovative Science, Technology, Engineering and Math (STEM) education component of Tennessee’s $500M First To The Top federal education reform funding program.

Prior to her current role at TTDC, Dr. Wisner-Lynch was Director of Applied Research at BioMimetic Therapeutics, Inc. in Franklin, TN, a biopharmaceutical company focused on the development and commercialization of combination device products for the repair/regeneration of orthopedic injuries

A native of Midland, Michigan, Dr. Wisner-Lynch received a Bachelor of Science degree in chemistry from Lamar University, Beaumont, Texas and a Doctor of Dental Surgery degree from the Medical College of Virginia-Virginia Commonwealth University in Richmond, Virginia. She received surgical specialty and research training in Periodontics at the Harvard School of Dental Medicine, as the first Astra Pharmaceutical Research Fellow. In addition to a surgical specialty certificate in periodontics she was concurrently awarded a Doctor of Medical Science degree from Harvard Medical School for research focused on gene expression in a naturally occurring bone disease model. Dr. Wisner-Lynch then served as a consultant to a world-wide pharmaceutical company, with products utilized in bone regeneration procedures in periodontics and craniomaxillofacial surgery while concurrently practicing periodontics in a multi-practitioner setting.

Dr. Wisner-Lynch is a member of the American Academy of Periodontology and is a member of the Board of Directors for Tennessee Technology Development Corporation, Tennessee Valley Corridor and Mind2Marketplace as well as serving on the Board of Trustees for the Adventure Science Center and Battle Ground Academy and serving as Board Chair for STEM Preparatory Academy, a recently approved charter school in Metro Nashville Public Schools.


Chiatogu Onyewu

PhD Career Connections presents
Dr. Chiatogu Onyewu
AAAS Science & Technology Policy Fellow, 2010-2012
National Institutes of Health
National Heart, Lung, and Blood Institute (NHLBI)
Division for the Application of Research Discoveries (DARD)

Friday, September 30, 2011
2:00PM
512 Light Hall

Advance registration requested at https://www.surveymonkey.com/s/PhDCareerConnections_Oct11
Sponsored by the BRET Office of Career Development

Dr. Onyewu is an American Association for the Advancement of Science (AAAS) Science & Technology Policy Fellow with the Division for the Application of Research Discoveries (DARD) at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD. She supports current NHBLI efforts to develop and implement evidence-based clinical practice guidelines for adult cardiovascular disease. In addition to documenting the systematic processes and policies that govern this rigorous approach to science translation, Dr. Onyewu is also involved in the development of a new NHLBI initiative focused on reducing cardiovascular risk across the lifespan. She is particularly committed to addressing health disparities, and was recently selected as a 2011 Translational Health Disparities Course Scholar by the National Institute of Minority Health and Health Disparities (NIMHD).

Dr. Onyewu previously conducted health disparities research as a United Negro College Fund/Merck (UNCF/Merck) Postdoctoral Fellow in the Research Center for Genetic Medicine at Children’s National Medical Center in Washington, D.C. As Study Director for the Assessing Inherited Markers of Metabolic Syndrome in the Young (AIMM Young) Research Study, Dr. Onyewu worked to identify genetic risk factors associated with metabolic syndrome and related diseases among African American college students. Her research interests center around the design of unique interventions that incorporate personalized medicine approaches and foster cardiovascular disease prevention among minority young adults. She has discussed her work and the future promise of genetic testing as a guest panelist on the PBS television program, To the Contrary, and served as Co-Chair of the Medical and Health Stakeholders group for the D.C. Overweight and Obesity Action Plan. While at Children’s National, she contributed to the formation of its Obesity Institute, and worked to establish an annual symposium series. Dr. Onyewu was a Robert & Jane Meyerhoff Scholar at the University of Maryland, Baltimore County where she received her B.S. degree in Biology in 1999. She completed the Medical Scientist Training Program at Duke University in 2007, with a doctorate degree in Pharmacology.

 


PhD Career Connections presents
Dr. Jerome Jourquin
Scientific Grants Manager, Susan G. Komen for the Cure

Wednesday, December 14, 2011
4:00-5:00PM
411A-D Light Hall

Advance registration requested at https://www.surveymonkey.coms/PhDCareerConnections_Dec11
Sponsored by the BRET Office of Career Development

Dr. Jerome Jourquin joined Susan G. Komen for the Cure (Komen) in January of 2011 as Scientific Grants Manager of the $298 million Research Programs portfolio. For the last 30 years, Komen has been dedicated in finding the cures to breast cancer through raising awareness, advocating for patients, and funding innovative research. Dr. Jourquin is involved with all facets of Grants Management at Komen: from conducting peer-review of new applications to annually evaluating the progress made by the funded scientists. As a scientist, he is also responsible for communicating about the current science in Komen’s portfolio to the Komen Affiliate network, patient advocates, and donors.

Prior to joining Komen, Dr. Jourquin was a post-doctoral fellow in the Department of Cancer Biology at Vanderbilt. He joined Dr. Vito Quaranta’s laboratory after completing his Ph.D. in Neurosciences in 2003 at the University of Aix-Marseilles, France. His thesis work focused on studying extracellular matrix-cell interactions in synaptic plasticity. Applying his Cell Biology expertise to breast cancer research, Dr. Jourquin became part of a multidisciplinary team of experimentalists, mathematicians, engineers, and bioinformaticists studying cancer invasion at the NCI-funded Center for Cancer Systems Biology at Vanderbilt (CCSB@V). With a specific interest in data mining and data sharing, Dr. Jourquin also completed in 2010 a Masters in Bioinformatics at Vanderbilt, working with Dr. Bing Zhang in the Department of Biomedical Informatics to create GLAD4U, a web-service designed to build prioritized gene lists based on user queries. Dr. Jourquin’s research studies have been published in various scientific journals.


PhD Career Connections presents
Entrepreneurship

A Panel Discussion with
Dr. Jim Stefansic, Cofounder and COO of Pathfinder Therapeutics
Dr. Mark Harris, Founder and CEO of NextGxDx

Monday, January 16, 2012
4:00-5:00PM
202 Light Hall

Advance registration requested at http://www.eventbrite.com/event/2621312416
Co-Sponsored by the BRET Office of Career Development and the TechVenture Challenge

Dr. Jim Stefansic is Co-Founder and COO of Pathfinder Therapeutics, Inc., the developer of an image-guided “GPS” device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resection and/or ablation) in soft-tissue organs. Dr. Stefansic is an expert in the field of image guided surgery. Before joining Pathfinder full-time as the Chief Operating Officer early in 2005, Dr. Stefansic worked as a Research Assistant Professor in the Departments of Psychology and Neurosurgery at Vanderbilt University, where his R&D efforts were focused on functional neuroimaging and image-guided neurosurgery. He received his doctorate in biomedical engineering in 2000 from Vanderbilt University, where his research focus was image-guided liver surgery, and his MBA in 2005 from the Jack C. Massey Graduate School of Business at Belmont University. Since co-founding Pathfinder in mid-2004 , Jim has lead R&D efforts and performed many operational duties, including finance and fundraising, business development, and FDA regulatory approval. He has also served as the principal investigator on $3.4 million in small business innovative research grants awarded to Pathfinder.

Dr. Mark Harris is an entrepreneur at the intersection of science and technology. He founded NextGxDx in 2010 to address physicians’ need for a more efficient method of finding and ordering the right genetic test. Previously, Dr. Harris was brought into Thermo Fisher Scientific’s leadership development program, specifically to manage a sequencing project at Athena Diagnostics. At Athena, Dr. Harris developed the business case and implementation plan to transition Athena’s genetic tests onto a next generation sequencing platform. Dr. Harris earned a joint PhD/MBA from Vanderbilt University’s School of Medicine and the Owen Graduate School of Management. His dissertation research focused on cancer biology and biochemistry.


Clinical Research Management

PhD Career Connections presents
Dr. Ines Macias-Perez
Senior Program Manager, Hematologic Malignancies and Bone Marrow Transplant Research Program, Sarah Cannon Research Institute

Wednesday, February 8, 2012
4:00-5:00PM
206 Preston Research Building

Advance registration requested at http://www.eventbrite.com/event/2732578215
Sponsored by the BRET Office of Career Development

Dr. Ines Macias-Perez is a Senior Program Manager at Sarah Cannon Research Institute. She oversees the development of investigator-initiated clinical trials for the Hematologic Malignancies Research Program. She ensures the ongoing development of investigator-initiated clinical trials by researching and drafting trial concepts. She is responsible for establishing and maintaining collaborative opportunities and relationships with external partners including translational researchers, our funding partners at pharma/biotech companies and investigators practicing in academic institutions. She also manages the pipeline of industry-sponsored and investigator-initiated studies to minimize gaps and competing studies for our network of sites across the U.S. and U.K.


Regulatory Affairs

PhD Career Connections presents
Dr. Bryan Voss
Cumberland Pharmaceuticals, Inc.

Tuesday, March 20, 2012
4:00-5:00PM
MRB3 1220

Advance registration requested at http://www.eventbrite.com/event/2744491849

Co-sponsored by the BRET Office of Career Development and TechVenture Challenge

Dr. Bryan Voss, a 2007 graduate of the Vanderbilt Pharmacology Training Program, is a Research Scientist at Cumberland Pharmaceuticals in Nashville. Dr. Voss’ team develops new pharmaceutical products, through which he is involved in virtually all phases of the drug development process. Dr. Voss evaluates new product ideas, spearheads the development of animal and human study protocols, identifies qualified investigators to execute the studies and liaises with the FDA to ensure a smooth path to approval. Dr. Voss also manages Cumberland’s Investigator-Initiated Research Program and leads their Scientific/Medical writing efforts for peer-reviewed publications.


Business of Healthcare

PhD Career Connections presents
Business of Healthcare

A Panel Discussion with
Mr. Chris Calton, Director of Banking, Avondale Partners
Mr. John Lam, Chief Creative Strategist, Co-Founder of Lam-Andrews
Ms. Kim Ramko, Principal for Americas Life Sciences Sector Lead, Ernst & Young
Ms. Rena Goins, Senior Director Specialty Markets, D2 Pharma Consulting

Tuesday, April 10, 2012
4:00-5:00PM
411 Light Hall

Advance registration requested at http://www.eventbrite.com/event/2732660461
Sponsored by the BRET Office of Career Development

Panelists represent the fields of healthcare marketing/PR, healthcare consulting, and healthcare investment banking.


Medical Science Liaison

PhD Career Connections presents
Dr. Kathy Amiri
Oncology Regional Medical Liaison
Amgen

Tuesday, May 29, 2012
4:00-5:00PM
512 Light Hall

Advance registration requested at http://www.eventbrite.com/event/2856157845
Sponsored by the BRET Office of Career Development

Dr. Kathy Amiri is a Senior Medical Liaison with Amgen Oncology. She develops and maintains professional relationships with prominent healthcare providers and key decision makers as they relate to company’s products. She communicates key information about the company and its mission; provides key scientific and clinical information about company’s products; provides a conduit for communication between company’s Research and the medical community regarding ideas for future research with company’s products; and provides corporate value through demonstrated leadership and participation in strategic thinking.
Prior to joining Amgen, Dr. Amiri served as the Director of the Translational Research Laboratory at Vanderbilt Ingram Cancer Center, where she oversaw preclinical and clinical studies. She was responsible for establishing and maintaining collaborative opportunities with internal as well as external partners including translational researchers, pharma/biotech companies and investigators practicing in academic institutions.
Dr. Amiri is a native of Iran, but grew up I Sweden. She moved to US for her Higher Education and graduated from Wittenberg University in 2000, receiving a bachelor’s degree in Biology. She later attended Vanderbilt University/Meharry Medical College where she studied in the laboratory of Dr. Ann Richmond and received her Doctorate degree in Cancer Biology in 2005.